{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:34:50Z","timestamp":1767900890947,"version":"3.49.0"},"reference-count":34,"publisher":"BMJ","issue":"S4","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["grant number II-LB-0214-20005"],"award-info":[{"award-number":["grant number II-LB-0214-20005"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1136\/sextrans-2016-053072","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T00:50:28Z","timestamp":1499388628000},"page":"S65-S68","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":38,"title":["Rapid accurate point-of-care tests combining diagnostics and antimicrobial resistance prediction for<i>Neisseria gonorrhoeae<\/i>and<i>Mycoplasma genitalium<\/i>"],"prefix":"10.1136","volume":"93","author":[{"given":"Syed Tariq","family":"Sadiq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulvia","family":"Mazzaferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,7,6]]},"reference":[{"key":"key-10.1136\/sextrans-2016-053072-1","doi-asserted-by":"crossref","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS ONE"},{"key":"key-10.1136\/sextrans-2016-053072-2","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/jdv.13849","article-title":"2016 European guideline on Mycoplasma genitalium infections","volume":"30","author":"Jensen","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.1136\/sextrans-2016-053072-3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1128\/CMR.00006-11","article-title":"Mycoplasma genitalium: from Chrysalis to multicolored butterfly","volume":"24","author":"Taylor-Robinson","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"key-10.1136\/sextrans-2016-053072-4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/cid\/civ312","article-title":"Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis","volume":"61","author":"Lis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/sextrans-2016-053072-5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/sextrans-2013-051147","article-title":"An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoeae in genitourinary medicine clinics in England","volume":"90","author":"Turner","year":"2014","journal-title":"Sex Transm Infect"},{"key":"key-10.1136\/sextrans-2016-053072-6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/sextrans-2011-050355","article-title":"Comparative effectiveness of a rapid point-of-care test for detection of Chlamydia trachomatis among women in a clinical setting","volume":"89","author":"Huang","year":"2013","journal-title":"Sex Transm Infect"},{"key":"key-10.1136\/sextrans-2016-053072-7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/14787210.2014.860356","article-title":"State of the art syphilis diagnostics: rapid point-of-care tests","volume":"12","author":"Kay","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key-10.1136\/sextrans-2016-053072-8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/14787210.2014.880651","article-title":"Point of care diagnostics for sexually transmitted infections: perspectives and advances","volume":"12","author":"Gaydos","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key-10.1136\/sextrans-2016-053072-9","doi-asserted-by":"crossref","first-page":"4386127","DOI":"10.1155\/2016\/4386127","article-title":"A systematic review of point of care testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis","volume":"2016","author":"Herbst de Cortina","year":"2016","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.1136\/sextrans-2016-053072-10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrurol.2016.268","article-title":"Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium","volume":"14","author":"Unemo","year":"2017","journal-title":"Nat Rev Urol"},{"key":"key-10.1136\/sextrans-2016-053072-11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/sextrans-2014-051997","article-title":"The performance of non-NAAT point-of-care (POC) tests and rapid NAAT tests for chlamydia and gonorrhoea infections. An assessment of currently available assays","volume":"91","author":"Brook","year":"2015","journal-title":"Sex Transm Infect"},{"key":"key-10.1136\/sextrans-2016-053072-12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12879-016-1573-4","article-title":"A novel point-of-care testing strategy for sexually transmitted infections among pregnant women in high-burden settings: results of a feasibility study in Papua New Guinea","volume":"16","author":"Badman","year":"2016","journal-title":"BMC Infect Dis"},{"key":"key-10.1136\/sextrans-2016-053072-13","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1469-0691.2010.03279.x","article-title":"Point-of-care tests for diagnosing infections in the developing world","volume":"16","author":"Peeling","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"key-10.1136\/sextrans-2016-053072-14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1109\/TBME.2010.2095851","article-title":"Evaluation of a novel electrochemical detection method for Chlamydia trachomatis: application for point-of-care diagnostics","volume":"58","author":"Pearce","year":"2011","journal-title":"IEEE Trans Biomed Eng"},{"key":"key-10.1136\/sextrans-2016-053072-15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st Century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"key-10.1136\/sextrans-2016-053072-16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0956462412472837","article-title":"2012 European guideline on the diagnosis and treatment of gonorrhoea in adults","volume":"24","author":"Bignell","year":"2013","journal-title":"Int J STD AIDS"},{"key":"key-10.1136\/sextrans-2016-053072-17","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"key-10.1136\/sextrans-2016-053072-18","unstructured":"Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections. Gonococcal Infections Chapter (Public Health Agency of Canada, 2013). http:\/\/www.phac-aspc.gc.ca\/std-mts\/sti-its\/cgsti-ldcits\/assets\/pdf\/section-5-6-eng.pdf"},{"key":"key-10.1136\/sextrans-2016-053072-19","volume-title":"Australian STI management guidelines for use in primary care","author":"Australasian Sexual Health Alliance","year":"2016"},{"key":"key-10.1136\/sextrans-2016-053072-20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/cid\/cit752","article-title":"High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options","volume":"58","author":"Pond","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/sextrans-2016-053072-21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jac\/dkv432","article-title":"Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy","volume":"71","author":"Pond","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key-10.1136\/sextrans-2016-053072-22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/QCO.0000000000000230","article-title":"Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: when, where, and how to use?","volume":"29","author":"Low","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.1136\/sextrans-2016-053072-23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrmicro3217","article-title":"Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance","volume":"12","author":"Goire","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"key-10.1136\/sextrans-2016-053072-24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/sti.2010.044230","article-title":"Point-of-care antibiotic susceptibility testing for gonorrhoea: improving therapeutic options and sparing the use of cephalosporins","volume":"86","author":"Sadiq","year":"2010","journal-title":"Sex Transm Infect"},{"key":"key-10.1136\/sextrans-2016-053072-25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance\u2014The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014","volume":"65","author":"Kirkcaldy","year":"2016","journal-title":"MMWR Surveill Summ"},{"key":"key-10.1136\/sextrans-2016-053072-26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12879-015-1013-x","article-title":"Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance","volume":"15","author":"Cole","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key-10.1136\/sextrans-2016-053072-27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/jac\/dkv321","article-title":"First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China","volume":"71","author":"Chen","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key-10.1136\/sextrans-2016-053072-28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2334-13-40","article-title":"Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011","volume":"13","author":"Olsen","year":"2013","journal-title":"BMC Infect Dis"},{"key":"key-10.1136\/sextrans-2016-053072-29","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/jac\/dkv146","article-title":"Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea","volume":"70","author":"Lee","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key-10.1136\/sextrans-2016-053072-30","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1099\/mic.0.036830-0","article-title":"The Swedish new variant of Chlamydia trachomatis: genome sequence, morphology, cell tropism and phenotypic characterization","volume":"156","author":"Unemo","year":"2010","journal-title":"Microbiology (Reading, Engl)"},{"key":"key-10.1136\/sextrans-2016-053072-31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/jac\/dkw397","article-title":"Identification of bacterial pathogens and antimicrobial resistance directly from clinical urines by nanopore-based metagenomic sequencing","volume":"72","author":"Schmidt","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"(Suppl 1)","key":"key-10.1136\/sextrans-2016-053072-32","first-page":"A13","article-title":"Whole genome sequencing to predict Neisseria gonorrhoeae antibiotic susceptibility: toward tailored antimicrobial therapy","volume":"92","author":"Phillips","year":"2016","journal-title":"Sex Transm Infect"},{"key":"key-10.1136\/sextrans-2016-053072-33","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkx067","article-title":"WGS to predict antibiotic MICs for Neisseria gonorrhoeae","author":"Eyre","year":"2017","journal-title":"J Antimicrobial Chemother"},{"key":"key-10.1136\/sextrans-2016-053072-34","doi-asserted-by":"crossref","unstructured":"Turner K, Christensen H, Adams E, et al. Analysis of the potential impact of a point-of-care test to distinguish gonorrhoea cases caused by antimicrobial-resistant and susceptible strains of Neisseria gonorrhoeae. https:\/\/amr-review.org\/sites\/default\/files\/GCDiagnostictestmodel_WORKINGPAPER.pdf (accessed 15 Mar 2017).","DOI":"10.1136\/bmjopen-2016-015447"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2016-053072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:14:40Z","timestamp":1601115280000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2016-053072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,6]]},"references-count":34,"journal-issue":{"issue":"S4","published-online":{"date-parts":[[2017,12,8]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1136\/sextrans-2016-053072"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2016-053072","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,6]]}}}